Pay in 4 interest-free payments of $6.48 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
18 CeroveckiT.BojanicI.BrcicL.RadicB.VukojaI.SeiwerthS.et al (2010)
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
(For Research Use Only Not for Human or Animal Consumption) This blend combines two research peptides into a single formulation
Product Name: AOD-9604 Catalogue Number: AOD2-024 Unit Size: Multiple vial sizes available Other Names: AOD9604, Tyr-hGH (177-191) Form: Lyophilized solid AOD-9604 has been characterized in published rodent and adipocyte-culture work reporting increased lipolytic activity in isolated fat cells and reductions in adipose mass in obese mouse models, recorded without the insulin sensitivity changes or insulin-like growth factor 1 elevation that accompany intact growth hormone
